Infection of human T lymphocytes with varicella-zoster virus: an analysis with viral mutants and clinical isolates

J Virol. 2000 Feb;74(4):1864-70. doi: 10.1128/jvi.74.4.1864-1870.2000.

Abstract

Varicella-zoster virus (VZV) disseminates in the body in peripheral blood mononuclear cells during chickenpox. Up to 1 in 10,000 mononuclear cells are infected during the viremic phase of the disease. We developed an in vitro system to infect human mononuclear cells with VZV by using umbilical cord blood. In this system, 3 to 4% of T cells were infected with VZV. VZV mutants unable to express certain genes, such as open reading frame 47 (ORF47) or ORF66, were impaired for growth in T cells, while other mutants showed little difference from parental virus. VZV unable to express ORF47 was even more impaired for spread from umbilical cord blood cells to melanoma cells in vitro. Early-passage clinical isolates of VZV infected T cells at a similar rate to the Oka vaccine strain; however, the clinical isolates were more efficient in spreading from infected T cells to melanoma cells. This in vitro system for infecting human T cells with VZV should be useful for identifying cellular and viral proteins that are important for virus replication in T cells and for the spread of virus from T cells to other cells.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Cells, Cultured
  • Chickenpox / virology
  • Coculture Techniques
  • Herpes Zoster / virology
  • Herpesvirus 3, Human / genetics
  • Herpesvirus 3, Human / growth & development
  • Herpesvirus 3, Human / physiology*
  • Humans
  • Leukocytes, Mononuclear / cytology
  • Mutation
  • Protein Kinases / metabolism
  • T-Lymphocytes / cytology
  • T-Lymphocytes / virology*
  • Tumor Cells, Cultured
  • Viral Vaccines

Substances

  • Viral Vaccines
  • Protein Kinases
  • Varicella-Zoster ORF47-associated protein kinase